We also tested the effects on the survival of patients with tumor stages pT2-pT4 (n = 33), and, in this larger but more heterogeneous group of patients, HOTAIR rs12826786 still maintained its prognostic value (CT vs. CC: HR = 2.865 [1.026–7.999], p = 0.044; TT+CT vs. CC: HR = 2.746 [1.046–7.210], p = 0.040; Supplementary Table S4). The gene discussed is HOTAIR; the disease is neoplasm.